Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$88.76
+0.7%
$91.17
$81.97
$139.06
$153.59B0.6311.39 million shs10.95 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$570.00
+1.6%
$563.07
$506.91
$769.98
$44.24B1.56587,600 shs556,827 shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$416.55
+1.3%
$442.17
$396.68
$603.88
$145.58B1.462.31 million shs2.60 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$24.68
+0.3%
$25.00
$18.25
$30.42
$4.00B0.883.29 million shs2.07 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.99%-1.88%+5.06%-19.89%-34.45%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
+1.63%+1.57%+7.79%-2.89%+9.05%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+1.34%-0.48%-1.09%-13.71%-18.67%
Envista Holdings Corporation stock logo
NVST
Envista
+0.55%+5.23%+6.21%-5.28%+33.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$88.76
+0.7%
$91.17
$81.97
$139.06
$153.59B0.6311.39 million shs10.95 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$570.00
+1.6%
$563.07
$506.91
$769.98
$44.24B1.56587,600 shs556,827 shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$416.55
+1.3%
$442.17
$396.68
$603.88
$145.58B1.462.31 million shs2.60 million shs
Envista Holdings Corporation stock logo
NVST
Envista
$24.68
+0.3%
$25.00
$18.25
$30.42
$4.00B0.883.29 million shs2.07 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.99%-1.88%+5.06%-19.89%-34.45%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
+1.63%+1.57%+7.79%-2.89%+9.05%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+1.34%-0.48%-1.09%-13.71%-18.67%
Envista Holdings Corporation stock logo
NVST
Envista
+0.55%+5.23%+6.21%-5.28%+33.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$118.3833.37% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.64
Moderate Buy$751.0031.75% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$571.2837.15% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.6716.16% Upside

Current Analyst Ratings Breakdown

Latest IDXX, NVST, ABT, and ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price Target$120.00 ➝ $102.00
6/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price Target$520.00 ➝ $515.00
6/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
Lower Price TargetOverweight$34.00 ➝ $32.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$580.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetSell$440.00 ➝ $366.00
5/27/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price Target$558.00
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/19/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
5/18/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$650.00 ➝ $520.00
5/11/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
DowngradeHold (C+)Hold (C)
5/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
DowngradeHold (C)Hold (C-)
(Data available from 6/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.49$7.04 per share12.61$30.35 per share2.92
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B10.45$15.33 per share37.18$20.10 per share28.36
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B14.66$9.40 per share44.31$50.52 per share8.25
Envista Holdings Corporation stock logo
NVST
Envista
$2.72B1.48$2.18 per share11.33$18.89 per share1.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5724.8614.671.4713.90%17.62%10.01%7/16/2026 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$13.5841.9734.483.0724.63%70.87%32.56%8/3/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2550.4942.463.2828.15%15.98%14.07%7/28/2026 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.4160.1915.921.392.41%7.11%3.91%8/5/2026 (Estimated)

Latest IDXX, NVST, ABT, and ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 million$705.50 million
5/5/2026Q1 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.41$3.47+$0.06$3.47$1.12 billion$1.14 billion
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.84%+10.39%70.59%54 Years
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A

Latest IDXX, NVST, ABT, and ISRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/12/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.87%7/15/20267/15/20268/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.12
0.82
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.44
2.06

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.88 million78.26 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.73 million161.12 millionOptionable

Recent News About These Companies

Envista (NVST) Q1 2026 Earnings Transcript
Envista: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$88.76 +0.58 (+0.66%)
Closing price 06/15/2026 03:59 PM Eastern
Extended Trading
$88.68 -0.08 (-0.09%)
As of 06/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$570.00 +9.12 (+1.63%)
Closing price 06/15/2026 04:00 PM Eastern
Extended Trading
$569.90 -0.10 (-0.02%)
As of 06/15/2026 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$416.55 +5.49 (+1.34%)
Closing price 06/15/2026 04:00 PM Eastern
Extended Trading
$415.50 -1.05 (-0.25%)
As of 06/15/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Envista stock logo

Envista NYSE:NVST

$24.68 +0.08 (+0.32%)
Closing price 06/15/2026 03:59 PM Eastern
Extended Trading
$24.68 +0.00 (+0.00%)
As of 06/15/2026 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.